Used primarily in pharmaceutical research as a potent antagonist of serotonin receptors, particularly 5-HT2A and 5-HT2C. It shows promise in the development of treatments for psychiatric disorders such as schizophrenia, depression, and anxiety due to its ability to modulate neurotransmitter activity. Its high selectivity and binding affinity make it a valuable tool in neuropharmacology studies aimed at understanding serotonin receptor function. Additionally, it has been investigated for potential use in managing substance abuse disorders, owing to its influence on dopaminergic and serotonergic pathways.